Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,158.00
Bid: 1,146.00
Ask: 1,148.00
Change: 22.00 (1.94%)
Spread: 2.00 (0.175%)
Open: 1,140.00
High: 1,158.00
Low: 1,120.00
Prev. Close: 1,136.00
CGEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues update on Georgia Capital (CGEO): FY23 NAV TR of 20% in sterling terms

23 Feb 2024 15:58

Edison Investment Research Limited Edison issues update on Georgia Capital (CGEO): FY23 NAV TR of 20% in sterling terms 23-Feb-2024 / 15:57 GMT/BST The issuer is solely responsible for the content of this announcement.


 

London, UK, 23 Februar 2024

 

Edison issues update on Georgia Capital (CGEO): FY23 NAV TR of 20% in sterling terms

Georgia Capital (GCAP) reported a Q423 NAV total return (TR) of 7.7% in Georgian lari (GEL) terms (3.4% in sterling terms), bringing the FY23 NAV TR to a strong 26.5% (20.4% in sterling terms). The considerable increase in the sterling share price of Bank of Georgia (BoG) was the main contributor, adding c 5.1% and 19.5% to GCAP’s opening NAV in Q423 and FY23, respectively. This was further assisted by positive revaluation of all large and investment-stage private holdings, except for the hospital business. In aggregate, GCAP’s private holdings added 1.9pp to its Q423 NAV TR. NAV-accretive buybacks of US$8.3m added a further 0.9pp.

Despite the c 50% appreciation in GCAP’s share price over the last 12 months, its shares still trade at a c 52% discount to NAV (when adjusted for the post-balance sheet change in BoG’s share price). If GCAP’s stake in BoG (which at end-2023 made up 33% of total portfolio value) was valued in line with the last closing price, GCAP’s current market cap would imply a wide 71% discount to the end-2023 fair value of its private assets (with GCAP’s enterprise value excluding BoG roughly equal to the fair value of the retail (pharmacy) business alone).

Click here to view the full report.

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: As a content-led investor-relations business, Edison helps companies stand out and meet the right shareholders. Edison’s integrated investor relations solution combines expert analyst content, digital targeting and active investor engagement. This drives liquidity and valuations by building bigger, better informed and more engaged investor audiences globally.

Edison has a proven history of increasing liquidity and valuations for its clients. Edison’s content can be viewed by all investors, anywhere in the world.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Milosz Papst +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube http://www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1844367 23-Feb-2024 

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
18th Mar 20225:53 pmRNSTransaction in Own Shares
17th Mar 20225:45 pmRNSTransaction in Own Shares
15th Mar 20225:38 pmRNSTransaction in Own Shares
15th Mar 20227:00 amRNSNotice of Georgia Capital's Investor Day
11th Mar 20223:29 pmRNSHolding(s) in Company
9th Mar 20226:03 pmRNSTransaction in Own Shares
9th Mar 20227:00 amRNSUS$ 5 million increase to the buyback programme
8th Mar 20225:38 pmRNSHolding(s) in Company
8th Mar 20225:38 pmRNSTransaction in Own Shares
7th Mar 20225:49 pmRNSTransaction in Own Shares
4th Mar 20225:40 pmRNSTransaction in Own Shares
3rd Mar 20226:31 pmRNSTransaction in Own Shares
3rd Mar 20225:58 pmRNSHolding(s) in Company
3rd Mar 20222:29 pmRNSHolding(s) in Company
3rd Mar 20222:28 pmRNSHolding(s) in Company
2nd Mar 20225:51 pmRNSTransaction in Own Shares
1st Mar 20226:28 pmRNSTotal Voting Rights
1st Mar 20226:27 pmRNSCancellation of Treasury Shares
1st Mar 20226:25 pmRNSTransaction in Own Shares
28th Feb 20225:59 pmRNSTransaction in Own Shares
25th Feb 20225:31 pmRNSTransaction in Own Shares
24th Feb 20225:02 pmRNSTransaction in Own Shares
24th Feb 202210:44 amRNSHolding(s) in Company
23rd Feb 20227:00 amRNSFinal Results
22nd Feb 20225:25 pmRNSTransaction in Own Shares
22nd Feb 20221:24 pmRNSHolding(s) in Company
21st Feb 20225:43 pmRNSTransaction in Own Shares
17th Feb 20225:11 pmRNSTransaction in Own Shares
16th Feb 20227:00 amRNSNotice of Results
14th Feb 20225:58 pmRNSTransaction in Own Shares
8th Feb 20225:33 pmRNSTransaction in Own Shares
4th Feb 20226:00 pmRNSTransaction in Own Shares
3rd Feb 20229:13 amRNSShare Cancellation
3rd Feb 20227:00 amRNSDisposal
2nd Feb 20227:00 amRNSTotal Voting Rights
2nd Feb 20227:00 amRNSTransaction in Own Shares
31st Jan 20226:10 pmRNSTransaction in Own Shares
31st Jan 20226:09 pmRNSHolding(s) in Company
31st Jan 20221:14 pmRNSResult of Meeting
28th Jan 20225:54 pmRNSTransaction in Own Shares
28th Jan 20224:32 pmRNSCorrection - Transaction in Own Shares
26th Jan 20227:00 amRNSDirector/PDMR Shareholding
24th Jan 20226:10 pmRNSTransaction in Own Shares
24th Jan 20221:28 pmRNSHolding(s) in Company
21st Jan 20225:19 pmRNSTransaction in Own Shares
21st Jan 20225:19 pmRNSDirector/PDMR Shareholding
21st Jan 20225:18 pmRNSDirector/PDMR Shareholding
20th Jan 20225:58 pmRNSTransaction in Own Shares
20th Jan 20227:00 amRNSUS$ 5 million increase to the buyback programme
19th Jan 20225:55 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.